438
Participants
Start Date
February 29, 2012
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
placebo
Placebo Comparator
donepezil
Active Comparator
ABT-126
low dose, middle dose, high dose
Site Reference ID/Investigator# 60910, Johannesburg
Site Reference ID/Investigator# 60912, George
Site Reference ID/Investigator# 60911, Belville
Site Reference ID/Investigator# 76073, Cape Town
Site Reference ID/Investigator# 56506, Staten Island
Site Reference ID/Investigator# 82994, Jenkintown
Site Reference ID/Investigator# 56514, West Palm Beach
Site Reference ID/Investigator# 56503, Delray Beach
Site Reference ID/Investigator# 56518, Tampa
Site Reference ID/Investigator# 60905, Poltava
Site Reference ID/Investigator# 62611, Elk Grove Village
Site Reference ID/Investigator# 77636, Wichita Falls
Site Reference ID/Investigator# 60909, Donetsk
Site Reference ID/Investigator# 60951, Moscow
Site Reference ID/Investigator# 60959, Moscow
Site Reference ID/Investigator# 60947, Saint Petersburg
Site Reference ID/Investigator# 60958, Saint Petersburg
Site Reference ID/Investigator# 60949, Saint Petersburg
Site Reference ID/Investigator# 60952, Saint Petersburg
Site Reference ID/Investigator# 60950, Saratov
Site Reference ID/Investigator# 60945, Kazan'
Site Reference ID/Investigator# 60955, Kazan'
Site Reference ID/Investigator# 60954, Kirov
Site Reference ID/Investigator# 60946, Novosibirsk
Site Reference ID/Investigator# 56504, Bennington
Site Reference ID/Investigator# 62565, Gdynia
Site Reference ID/Investigator# 62563, Poznan
Site Reference ID/Investigator# 62562, Szczecin
Site Reference ID/Investigator# 60906, Kiev
Site Reference ID/Investigator# 60960, Bath
Site Reference ID/Investigator# 60963, Blackburn
Site Reference ID/Investigator# 60962, Glasgow
Site Reference ID/Investigator# 60961, London
AbbVie (prior sponsor, Abbott)
INDUSTRY